Nexalin Technology, Inc. (NXL) Key Metrics
NXL valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $2.5M
- Enterprise value
- $3.0M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 11.3 10-yr median 28.6
- Price / book
- 2.6 10-yr median 1.7
- EV / EBITDA
- 0.0
- Dividend yield
- —
- Beta
- 4.11
NXL key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNXL valuation Price multiples at each fiscal year-end price.
NXL returns How much profit the business earns on the capital it uses.
NXL per-share figures Results divided by the shares outstanding at year-end.
NXL financial health Debt, liquidity and how easily interest is covered.
NXL efficiency & capital use Working capital cycle and where the cash goes.
NXL valuation history
NXL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NXL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NXL price vs earnings per share
NXL key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $9.1M | $25.4M | $3.0M | $5.5M | — | — | — |
| Enterprise value | $5.4M | $22.0M | $35,623 | −$781,049 | — | — | — |
| Price / sales | 30.3 | 150.8 | 26.9 | 4.1 | — | — | — |
| Price / book | 2.4 | 6.9 | 0.9 | 1.0 | — | — | — |
| EV / sales | 18.0 | 130.1 | 0.3 | -0.6 | — | — | — |
| Earnings yield | −89.9% | −29.9% | −156.0% | −31.1% | — | — | — |
| Free cash flow yield | −54.2% | −16.2% | −132.4% | −40.6% | — | — | — |
| Share price at fiscal year-end | $16.74 | $82.80 | $12.15 | $22.47 | — | — | — |
| Per share | |||||||
| Revenue per share | $0.55 | $0.55 | $0.45 | $5.44 | $0.59 | $1.00 | $0.85 |
| Earnings per share | −$15.05 | −$24.76 | −$18.96 | −$6.99 | −$25.05 | −$14.03 | −$20.69 |
| Operating cash flow per share | −$9.07 | −$12.84 | −$15.64 | −$9.12 | −$4.44 | −$3.56 | −$2.80 |
| Free cash flow per share | −$9.07 | −$13.39 | −$16.09 | −$9.12 | −$4.44 | −$3.56 | −$2.80 |
| Cash per share | $6.81 | $11.33 | $12.02 | $28.80 | $2.73 | $0.32 | $0.26 |
| Book value per share | $6.86 | $11.97 | $13.08 | $22.56 | −$6.93 | −$6.55 | −$4.86 |
| Tangible book value per share | $6.24 | $11.12 | $12.65 | $22.56 | −$6.93 | −$6.55 | −$4.86 |
| Capex per share | $0.18 | $0.55 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
| Debt per share | — | — | $0.02 | $3.11 | $3.50 | $2.99 | $3.41 |
| Shares outstanding | 546K | 307K | 245K | 243K | 243K | 243K | 243K |
| Change in shares outstanding | +77.9% | +25.3% | +1.0% | +0.1% | 0.0% | 0.0% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | −221.5% | −221.1% | −107.0% | −89.4% | — | — | — |
| Return on assets (ROA) | −185.6% | −193.7% | −84.0% | −41.5% | — | — | — |
| Return on tangible assets | −191.2% | −192.0% | −131.8% | −22.8% | −806.4% | — | — |
| Free cash flow margin | — | — | — | −167.7% | −747.4% | −355.7% | −327.1% |
| Financial health | |||||||
| Total debt | — | — | $4,463 | $755,260 | $850,050 | $726,012 | $826,766 |
| Cash & short-term investments | $3.7M | $3.5M | $2.9M | $7.0M | $661,778 | $78,436 | $63,427 |
| Net debt | −$3.7M | −$3.5M | −$2.9M | −$6.2M | $188,272 | $647,576 | $763,339 |
| Debt / equity | — | — | 0.00 | 0.14 | — | — | — |
| Debt / assets | — | — | 0.00 | 0.10 | 1.13 | 6.13 | 7.35 |
| Current ratio | 4.85 | 7.25 | 8.07 | 3.81 | 0.32 | 0.07 | 0.11 |
| Quick ratio | 4.70 | 6.93 | 7.70 | 3.73 | 0.31 | 0.06 | 0.09 |
| Interest coverage | — | — | -146.7 | -30.9 | -73.1 | -41.4 | -18.1 |
| Working capital | $3.4M | $3.4M | $3.0M | $5.5M | −$1.6M | −$1.4M | −$930,730 |
| Invested capital | $24,774 | $196,115 | $262,665 | −$759,988 | −$1.5M | −$942,754 | −$416,032 |
| Tangible asset value | $3.4M | $3.4M | $3.1M | $5.5M | −$1.7M | −$1.6M | −$1.2M |
| Net current asset value | $3.4M | $3.4M | $3.0M | $5.5M | −$1.7M | −$1.6M | −$1.2M |
| Graham net-net per share | $5.42 | $9.86 | $10.64 | $21.09 | −$7.19 | −$6.65 | −$5.00 |
| Capital allocation | |||||||
| Capex / revenue | 32.1% | 100.9% | 98.7% | 0.0% | 0.0% | 0.3% | 0.0% |
| Capex / depreciation | 4.50 | 11.27 | 25.69 | 0.00 | 0.00 | 1.51 | 0.01 |
| Stock-based compensation / revenue | 1,035.4% | 2,110.3% | 2,179.2% | 20.5% | 3,108.3% | 806.7% | 271.4% |
| R&D / revenue | 359.2% | 705.9% | 1,735.5% | 38.7% | 96.5% | — | — |
| SG&A / revenue | 2,502.1% | 3,968.6% | 3,485.0% | 211.2% | 4,262.8% | 1,433.8% | 701.8% |
| Efficiency | |||||||
| Days sales outstanding | 57.2 | 24.2 | 23.5 | 2.9 | 29.0 | 9.2 | 10.0 |
| Days of inventory on hand | 910.1 | 1,650.8 | 2,208.0 | 93.3 | 460.2 | 278.1 | 36.1 |
| Days payables outstanding | 1,191.0 | 1,573.4 | 5,810.8 | 754.8 | 11,106.9 | 4,937.4 | 542.7 |
| Cash conversion cycle (days) | -223.7 | 101.6 | -3,579.3 | -658.5 | -10,617.7 | -4,650.1 | -496.6 |
| Receivables turnover | 6.38 | 15.06 | 15.55 | 124.79 | 12.58 | 39.53 | 36.45 |
| Payables turnover | 0.31 | 0.23 | 0.06 | 0.48 | 0.03 | 0.07 | 0.67 |
| Inventory turnover | 0.40 | 0.22 | 0.17 | 3.91 | 0.79 | 1.31 | 10.10 |
| Asset turnover | 0.07 | 0.04 | 0.02 | 0.32 | 0.33 | 2.10 | 1.84 |
| Average receivables | $47,307 | $11,206 | $7,122 | $10,589 | $11,451 | $6,144 | $5,690 |
| Average payables | $200,264 | $157,742 | $408,950 | $751,080 | $652,478 | $392,816 | $324,470 |
| Average inventory | $153,026 | $165,499 | $155,395 | $92,890 | $27,033 | $22,127 | $21,598 |
| Intangibles / total assets | 7.2% | 6.2% | 2.9% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from NXL's annual financial statements (latest annual report filed March 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NXL valuation and financial ratios
Nexalin Technology earned a return on equity of −221.5% in fiscal 2025. The share count rose 125.2% from 243K to 546K over 6 years.
See the NXL income statement, the NXL chart for price history, or the NXL stock overview for the latest quote and news.
NXL key metrics FAQ
What is Nexalin Technology's return on equity?
Nexalin Technology's return on equity (ROE) was −221.5% in fiscal 2025: net income of -$8.2 million on average shareholders' equity of $3.7 million.
What is Nexalin Technology's free cash flow yield?
Nexalin Technology generated -$5.0 million of free cash flow in fiscal 2025, a free cash flow yield of −54.2% on its market value at year-end ($9.1 million).
What is Nexalin Technology's current ratio?
Nexalin Technology's current ratio was 4.85 at the end of fiscal 2025: current assets were 4.85 times current liabilities.